Suppr超能文献

相似文献

1
Allelic variants of complement genes associated with dense deposit disease.
J Am Soc Nephrol. 2011 Aug;22(8):1551-9. doi: 10.1681/ASN.2010080795. Epub 2011 Jul 22.
5
Causes of alternative pathway dysregulation in dense deposit disease.
Clin J Am Soc Nephrol. 2012 Feb;7(2):265-74. doi: 10.2215/CJN.07900811. Epub 2012 Jan 5.
7
Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy).
Eur J Pediatr. 2014 Jun;173(6):767-72. doi: 10.1007/s00431-013-2245-7. Epub 2014 Jan 3.
8
C3 glomerulopathy.
Contrib Nephrol. 2013;181:185-93. doi: 10.1159/000348654. Epub 2013 May 8.
9
Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
J Clin Invest. 2014 Jan;124(1):145-55. doi: 10.1172/JCI71866. Epub 2013 Dec 16.
10
Eculizumab for dense deposit disease and C3 glomerulonephritis.
Clin J Am Soc Nephrol. 2012 May;7(5):748-56. doi: 10.2215/CJN.12901211. Epub 2012 Mar 8.

引用本文的文献

1
Chronic kidney disease enhances alternative pathway activity: a new paradigm.
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.
2
Understanding rare genetic variants within the terminal pathway of complement system in preeclampsia.
Genes Immun. 2025 Feb;26(1):22-26. doi: 10.1038/s41435-024-00310-6. Epub 2024 Dec 17.
3
Individualised therapeutic approach to the patient with atypical haemolytic-uraemic syndrome.
Clin Med (Lond). 2024 Nov;24(6):100250. doi: 10.1016/j.clinme.2024.100250. Epub 2024 Oct 4.
6
7
C3 Glomerulopathy: A Review with Emphasis on Ultrastructural Features.
Glomerular Dis. 2022 Apr 12;2(3):107-120. doi: 10.1159/000524552. eCollection 2022 Jul.
8
Role of fluid-phase complement system regulation in the development of hepatitis C virus-associated glomerulonephritis.
PLoS One. 2022 Oct 13;17(10):e0276017. doi: 10.1371/journal.pone.0276017. eCollection 2022.
10
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.
Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.

本文引用的文献

1
Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
Am J Kidney Dis. 2010 Nov;56(5):977-82. doi: 10.1053/j.ajkd.2010.06.021. Epub 2010 Sep 15.
3
Anti-factor B autoantibody in dense deposit disease.
Mol Immunol. 2010 Apr;47(7-8):1476-83. doi: 10.1016/j.molimm.2010.02.002. Epub 2010 Mar 1.
4
A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2010 May;25(5):947-51. doi: 10.1007/s00467-009-1415-3. Epub 2010 Jan 27.
6
Functions of C5a receptors.
J Mol Med (Berl). 2009 Apr;87(4):375-8. doi: 10.1007/s00109-009-0442-7. Epub 2009 Feb 3.
7
Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.
Kidney Int. 2009 May;75(9):952-60. doi: 10.1038/ki.2008.657. Epub 2009 Jan 28.
8
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):882-7. doi: 10.1073/pnas.0810860106. Epub 2009 Jan 9.
10
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
Blood. 2008 Dec 15;112(13):4948-52. doi: 10.1182/blood-2008-01-133702. Epub 2008 Sep 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验